Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

KRON Kronos Bio Inc

1,01

-0,025 (-2,42%)

01 Feb 2025 - Geschlossen

Verzögert um 15 Minuten

California Biotech Stock Bid Up Prior To Opening Bell On Major Announcement

A California-based biotech company is already stealing the show during Wednesday’s premarket after the company announced a CEO transition and an estimated 83% reduction in...

To read the full story on AllPennyStocks.com, click here.

Kronos Bio (NASDAQ:KRON)
Historical Stock Chart
Von Jan 2025 bis Feb 2025

Click Here for more Kronos Bio Charts.

Kronos Bio (NASDAQ:KRON)
Historical Stock Chart
Von Feb 2024 bis Feb 2025

Click Here for more Kronos Bio Charts.

News Kronos Bio Inc

California Biotech Stock Bid Up Prior To Opening Bell On Major Announcement
Mittwoch 27 November 2024 (2 Monate vor) • AllPennyStocks.com

Kronos Bio Announces CEO Transition and Reduction in Force
Mittwoch 27 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Freitag 15 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024
Donnerstag 14 November 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 13 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives
Mittwoch 13 November 2024 (3 Monate vor) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Donnerstag 7 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Kronos Bio to Present Data at the ASH Annual Meeting from p300 KAT Inhibition Program in Multiple Myeloma
Dienstag 5 November 2024 (3 Monate vor) • GlobeNewswire Inc.

Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors
Mittwoch 23 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 16 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 16 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors
Mittwoch 9 Oktober 2024 (4 Monate vor) • GlobeNewswire Inc.

Weitere Kronos Bio Inc News-Artikel

Health Care Select Sector

Invesco QQQ Trust Series 1

Euro vs Sterling

Energy Select Sector SPDR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen